This perspective has argued that there is a continuing need for new cycles of antibiotic discovery and development. The genes found in the global resistomes are mobilizable with different frequencies to propel waves of resistant bacteria to each generation of newly introduced antibiotics. Given that the past half century has turned up few new molecular scaffolds, the fine tuning of existing frameworks by medicinal chemists may be approaching an asymptotic limit.